Trials / Completed
CompletedNCT01055366
ELAZOP Switching Study in Korea
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of switching to ELAZOP from prior pharmacotherapy in patients with open-angled glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Elazop (Azarga) | Administer one drop of ELAZOP in treated eye(s) twice a day for up to 12 weeks |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2010-01-25
- Last updated
- 2012-12-17
Locations
10 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01055366. Inclusion in this directory is not an endorsement.